Your browser doesn't support javascript.
loading
Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry.
Ibragimova, Khava I E; Geurts, Sandra M E; Croes, Sander; Erdkamp, Frans; Heijns, Joan B; Tol, Jolien; Vriens, Birgit E P J; Aaldering, Kirsten N A; Dercksen, Marcus W; Pepels, Manon J A E; Peters, Natascha A J B; van de Winkel, Linda; Tilli, Dominique J P; Vriens, Ingeborg J H; de Boer, Maaike; Tjan-Heijnen, Vivianne C G.
Affiliation
  • Ibragimova KIE; Department of Medical Oncology, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands.
  • Geurts SME; GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
  • Croes S; Department of Medical Oncology, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands.
  • Erdkamp F; GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
  • Heijns JB; Department of Medical Oncology, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands.
  • Tol J; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, The Netherlands.
  • Vriens BEPJ; Department of Medical Oncology, Amphia, Breda, The Netherlands.
  • Aaldering KNA; Department of Medical Oncology, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
  • Dercksen MW; Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands.
  • Pepels MJAE; Department of Internal Medicine, Laurentius Hospital, Roermond, The Netherlands.
  • Peters NAJB; Department of Medical Oncology, Máxima Medical Center, Eindhoven, The Netherlands.
  • van de Winkel L; Department of Internal Medicine, Elkerliek Hospital, Helmond, The Netherlands.
  • Tilli DJP; Department of Internal Medicine, Sint Jans Gasthuis, Weert, The Netherlands.
  • Vriens IJH; Department of Internal Medicine, St Anna Hospital, Geldrop, The Netherlands.
  • de Boer M; Department of Medical Oncology, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands.
  • Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands.
Breast Cancer Res Treat ; 188(2): 571-581, 2021 Jul.
Article in En | MEDLINE | ID: mdl-33743103
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: Breast Cancer Res Treat Year: 2021 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: Breast Cancer Res Treat Year: 2021 Type: Article Affiliation country: Netherlands